N/A
Completed N=114
A Multi-Center Investigation of Patient Acceptability of OPTI-FREE RepleniSH® Multi-Purpose Disinfecting Solution (MPDS)
Source: ClinicalTrials.gov NCT00772707 ↗Enrolled (actual)
114
Serious AEs
0.0%
Results posted
Sep 2012
Primary outcomePrimary: Comfort Ratings at Baseline — 86; 59; 57; 81 Percentage of Participants
Summary
The purpose of this study was to demonstrate that current successful fulltime daily wear soft contact lens wearers using competitive multi-purpose solutions will note improved comfort when using OPTI-FREE RepleniSH®.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Comfort Ratings at Baseline |
86; 59; 57; 81 | — |
| PRIMARY Comfort Ratings at 30 Days |
92; 88; 91; 91; 71; 81 | — |
Eligibility Criteria
Inclusion Criteria
- Participants must be between 18 and 65 years of age.
- Must wear daily wear soft contact lenses a minimum of 8 hours per day,7 days a week.
- Must be wearing a planned replacement soft lens in a 2 week or monthly replacement modality.
- Must be using either COMPLETE Multi-Purpose Solution (MPS) Easy Rub or ReNu MultiPlus brand solution for at least 30 continuous days prior to enrollment.
- Must be free of any contact lens-related symptoms with regard to comfort and vision throughout their wearing hours prior to enrollment, with the exception of end-of-day dryness not limiting all day wear.
- Must have best corrected distance visual acuity, with contact lenses, of 20/30 or better in each eye.
- Must be willing to maintain pre-enrollment systemic medication regimens during the study.
- Must be willing to not use any topical medications or rewetting drops during the 30 day clinical trial duration.
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria
- Has used any topical medication or rewetting drops for 7 days prior to enrollment.
- Achieves best visual correction by monovision.
- Has modified their systemic medications within 30 days prior to enrollment.
- Has switched brands of cosmetics during the 30 days prior to the study.
- Has a history of allergy to any study product ingredients.
- Is unwilling or unable to meet the study visit timeline.
- Has any active corneal, eyelid or other anterior segment inflammation or infection, which, in the opinion of the Investigator, would adversely affect successful contact lens wear.
- Other protocol-defined exclusion criteria may apply.
Data sourced from ClinicalTrials.gov (NCT00772707). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.